TRXB Trex Bio, Inc.

Fundamentals / CIK 0002139097 / USD

Trex Bio, Inc. reported $88.75M in total assets through September 30, 2026 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open TRXB in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

No annual income statement rows are available in SEC EDGAR CompanyFacts for TRXB.

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-09-30 2025-06-30 2025-03-31
Research & Development $11.43M -- -- $6.97M -- --
Total Operating Expenses $13.92M -- -- $8.71M -- --
Operating Income -$13.92M -- -- -$8.71M -- --
Interest Income $768K -- -- $853K -- --
Income Before Tax -$13.15M -- -- -$7.86M -- --
Income Tax Expense $88K -- -- $0 -- --
Net Income -$13.24M -$13.09M -$16.22M -$7.86M -$8.33M -$9.39M
Basic EPS -$10.06 -- -- -$7.58 -- --
Diluted EPS -$10.06 -- -- -$7.58 -- --
Basic Shares Outstanding 1.3M -- -- 1.0M -- --
Diluted Shares Outstanding 1.3M -- -- 1.0M -- --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

No annual balance sheet rows are available in SEC EDGAR CompanyFacts for TRXB.

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2025-12-31
Cash & Cash Equivalents $16.81M $15.19M
Short-Term Investments $61.34M $52.53M
Cash & Short-Term Investments $78.20M $67.72M
Total Current Assets $79.85M $71.43M
Property, Plant & Equipment, Net $826K $482K
Other Non-Current Assets $5.35M $538K
Total Non-Current Assets $8.91M $1.70M
Total Assets $88.75M $73.13M
Accounts Payable $1.72M $371K
Total Current Liabilities $10.53M $4.99M
Other Non-Current Liabilities $103K $72K
Total Non-Current Liabilities $3.50M $1.24M
Total Liabilities $14.03M $6.24M
Total Debt (incl. Leases) $2.81M $717K
Common Stock $0 $0
Retained Earnings -$136.8M -$94.26M
Accumulated Other Comp. Income -$151K $17K
Total Stockholders' Equity -$134.1M -$92.12M
Total Equity -$134.1M -$92.12M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

No annual cash flow statement rows are available in SEC EDGAR CompanyFacts for TRXB.

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-09-30 2025-06-30 2025-03-31
Net Income -$13.24M -$13.09M -$16.22M -$7.86M -$8.33M -$9.39M
Stock-Based Compensation $178K -- -- $129K -- --

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

No annual ratios & growth rows are available in SEC EDGAR CompanyFacts for TRXB.

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-09-30 2025-06-30 2025-03-31
Current Ratio 7.58x -- -- -- -- --
Quick Ratio 7.43x -- -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0002139097) · from March 31, 2025 Data through September 30, 2026 · synced Nov 20, 2026, 05:48 UTC · Open in terminal